Cargando…
Comparison of topical 0.03% tacrolimus and homologous injectable platelet-rich plasma in the treatment of keratoconjunctivitis sicca in dogs
BACKGROUND AND AIM: Keratoconjunctivitis sicca (KCS) is predominantly an immune-mediated chronic inflammatory ocular disease that is commonly diagnosed in dogs. This study aimed to compare the conventional use of topical immunosuppressant tacrolimus 0.03% eye drops and a new therapy injectable homol...
Autores principales: | Estanho, Giovana José Garcia, Passareli, João Victor Goulart Consoni, Pando, Letícia da Silva, Vieira, Daniel Espinhosa, Nai, Gisele Alborghetti, Santarém, Cecília Laposy, Andrade, Silvia Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Veterinary World
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967714/ https://www.ncbi.nlm.nih.gov/pubmed/36855346 http://dx.doi.org/10.14202/vetworld.2023.134-143 |
Ejemplares similares
-
Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus
ointment in children with vernal keratoconjunctivitis
por: Saha, Bhawesh Chandra, et al.
Publicado: (2023) -
Therapeutic Effect of 0.03% Tacrolimus Ointment for Ocular Graft versus Host Disease and Vernal Keratoconjunctivitis
por: Ryu, Eun Hye, et al.
Publicado: (2012) -
Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East
por: Fiorentini, Sandra Flavia, et al.
Publicado: (2019) -
Safety and efficacy of topical tacrolimus 0.03% in the management of vernal keratoconjunctivitis: a non-randomized controlled clinical trial
por: Eltagoury, Mahmoud, et al.
Publicado: (2022) -
A New Conception of Keratoconjunctivitis Sicca
Publicado: (1946)